Low-dose sarin exposure produces long term changes in brain neurochemistry of mice

Neurochemical Research

Volumn 38, Issue 1, 2013, Pages 108-116

  Oswal, Dhawal P ^a   Garrett, Teresa L ^a   Morris, Mariana ^a   Lucot, James B ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

Author keywords

Dopamine; Monoamines; Neurotoxicity; Non cholinergic; Organophosphate; Sarin; Serotonin

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; HOMOVANILLIC ACID; NORADRENALIN; SARIN; SEROTONIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN LEVEL; BRAIN REGION; BRAIN TOXICITY; CAUDATE NUCLEUS; CELL DEATH; CHOLINERGIC TOXICITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOPAMINE METABOLISM; FRONTAL CORTEX; LD 50; MALE; MONOAMINERGIC SYSTEM; NEUROCHEMISTRY; NEUROPSYCHOLOGY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; TURNOVER TIME;

ANIMALS; BRAIN CHEMISTRY; CHEMICAL WARFARE AGENTS; CHOLINESTERASE INHIBITORS; CHOLINESTERASES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINE; ELECTROCHEMISTRY; FLUORESCEINS; FLUORESCENT DYES; HOMOVANILLIC ACID; MALE; MICE; MICE, INBRED C57BL; NOREPINEPHRINE; SARIN; SEROTONIN; WEIGHT LOSS;

MUS;

EID: 84871618803     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-012-0896-9     Document Type: Article

References (62)

1. Marrs TC, Maynard RL, Sidell FR (1996) Chemical warfare agents. Toxicology and treatment. Wiley, New York
2. Taylor P (2001) Anticholinesterase agents. In: Limbird LE, Hardman JG, Gilman AG (eds) Goodman and Gilman's the pharmacological basis of therapeutics. McGraw Hill, New-York, pp 175-191
3. McDonough JH, Shih TM (1997) Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology. Neurosci Biobehav Rev 21(5):559-579
4. Shih TM, Duniho SM, McDonough JH (2003) Control of nerve agent-induced seizures is critical for neuroprotection and survival. Toxicol Appl Pharmacol 188(2):69-80
5. Pope C, Karanth S, Liu J (2005) Pharmacology and toxicology of cholinesterase inhibitors: uses and misuses of a common mechanism of action. Elsevier, Amsterdam
6. Haley RW (1999) Is there a Gulf War syndrome? Lancet 354(9190):1645-1646
7. Nakajima T et al (1999) Sequelae of sarin toxicity at one and three years after exposure in Matsumoto, Japan. J Epidemiol 9(5):337-343
8. Barr DB et al (2004) Concentrations of dialkyl phosphate metabolites of organophosphorus pesticides in the U.S. population. Environ Health Perspect 112(2):186-200
9. Chao LL et al (2010) Effects of low-level exposure to sarin and cyclosarin during the 1991 Gulf War on brain function and brain structure in US veterans. Neurotoxicology 31(5):493-501
10. IOM (1995) Health consequences of service during the Persian Gulf War: initial findings and recommendations for immediate action. National Academy Press, Washington, DC
11. Couzin J (2004) Epidemiology. VA advisers link Gulf War illnesses to neurotoxins. Science 306(5693):26-27
12. Lashof JC, Arthur Caplan JB, Cross TP, Custis D, Hamburg DA, Johnson JA, Knox M, Landrigan PJ, Larson EL, Rios R, Taylor AK (1996) Presidential advisory committee on Gulf War Veterans' illnesses, in final report. Washington, DC
13. Stephens R et al (1995) Neuropsychological effects of long-term exposure to organophosphates in sheep dip. Lancet 345(8958):1135-1139
14. Rosenstock L et al (1991) Chronic central-nervous system effects of acuteorganophosphate pesticide intoxication. Lancet 338(8761):223-227
15. Bazylewicz-Walczak B, Majczakowa W, Szymczak M (1999) Behavioral effects of occupational exposure to organophosphorous pesticides in female greenhouse planting workers. Neurotoxicology 20(5):819-826
16. Farahat TM et al (2003) Neurobehavioural effects among workers occupationally exposed to organophosphorous pesticides. Occup Environ Med 60(4):279-286
17. Bouchard MF et al (2010) Attention-deficit/hyperactivity disorder and urinary metabolites of organophosphate pesticides. Pediatrics. 125(6):e1270-e1277
18. Bouchard MF et al (2011) Prenatal exposure to organophosphate pesticides and IQ in 7-year-old children. Environ Health Perspect 119(8):1189-1195
19. Engel SM et al (2011) Prenatal exposure to organophosphates, paraoxonase 1, and cognitive development in childhood. Environ Health Perspect 119(8):1182-1188
20. Scremin OU et al (2003) Delayed neurologic and behavioral effects of subtoxic doses of cholinesterase inhibitors. J Pharmacol Exp Ther 304(3):1111-1119
21. Russell RW et al (1986) Behavioral, neurochemical and physiological effects of repeated exposures to subsymptomatic levels of the anticholinesterase, soman. Neurobehav Toxicol Teratol 8(6):675-685
22. Mach M et al (2008) Delayed behavioral and endocrine effects of sarin and stress exposure in mice. J Appl Toxicol 28(2):132-139
23. Mamczarz J et al (2010) An acute exposure to a sub-lethal dose of soman triggers anxiety-related behavior in guinea pigs: interactions with acute restraint. Neurotoxicology 31(1):77-84
24. Morris M, Key MP, Farah V (2007) Sarin produces delayed cardiac and central autonomic changes. Exp Neurol 203(1):110-115
25. Kassa J, Koupilova M, Vachek J (2001) The influence of low-level sarin inhalation exposure on spatial memory in rats. Pharmacol Biochem Behav 70(1):175-179
26. Shih TM, Hulet SW, McDonough JH (2006) The effects of repeated low-dose sarin exposure. Toxicol Appl Pharmacol 215(2):119-134
27. Burchfiel JL, Duffy FH (1982) Organophosphate neurotoxicity: chronic effects of sarin on the electroencephalogram of monkey and man. Neurobehav Toxicol Teratol 4(6):767-778
28. Aldridge JE et al (2005) Alterations in central nervous system serotonergic and dopaminergic synaptic activity in adulthood after prenatal or neonatal chlorpyrifos exposure. Environ Health Perspect 113(8):1027-1031
29. Kant GJ, Kenion CC, Meyerhoff JL (1984) Effects of diisopropylfluorophosphate (DFP) and other cholinergic agents on release of endogenous dopamine from rat brain striatum in vitro. Biochem Pharmacol 33(11):1823-1825
30. Coudraylucas C et al (1987) Changes in brain monoamine content and metabolism induced by paraoxon and soman intoxication - effect of atropine. Xenobiotica 17(9):1131-1138
31. Christin D et al (2008) Effects of repeated low-dose soman exposure on monoamine levels in different brain structures in mice. Neurochem Res 33(5):919-926
32. Eells JB, Brown T (2009) Repeated developmental exposure to chlorpyrifos and methyl parathion causes persistent alterations in nicotinic acetylcholine subunit mRNA expression with chlorpyrifos altering dopamine metabolite levels. Neurotoxicol Teratol 31(2):98-103
33. Moreno M et al (2008) Long-term monoamine changes in the striatum and nucleus accumbens after acute chlorpyrifos exposure. Toxicol Lett 176(2):162-167
34. Casida JE, Quistad GB (2004) Organophosphate toxicology: safety aspects of nonacetylcholinesterase secondary targets. Chem Res Toxicol 17(8):983-998
35. Rocha ES et al (1999) Low concentrations of the organophosphate VX affect spontaneous and evoked transmitter release from hippocampal neurons: toxicological relevance of cholinesterase-independent actions. Toxicol Appl Pharmacol 159(1):31-40
36. Duysen EG et al (2001) Evidence for nonacetylcholinesterase targets of organophosphorus nerve agent: supersensitivity of acetylcholinesterase knockout mouse to VX lethality. J Pharmacol Exp Ther 299(2):528-535
37. Cooper JR, Bloom FE, Roth RH (1982) Catecholamines II - CNS aspects. In: The biochemical basis of neuropharmacology. Oxford University Press, New York, pp 173-222
38. Feldman RS, Meyer JS, Quenzer LF (1997) Catecholamines. In: Farley P (ed) Neuropsychopharmacology. Sinauer Associates Inc., Sunderland, pp 277-344
39. Haley RW (1997) Is there a Gulf War syndrome? Searching for syndromes by factor analysis of symptoms (vol 277, pg 215, 1997). JAMA 278(5):388
40. Maxwell DM, Brecht KM, O'Neill BL (1987) The effect of carboxylesterase inhibition on interspecies differences in soman toxicity. Toxicol Lett 39(1):35-42
41. Garrett TL et al (2010) A murine model for sarin exposure using the carboxylesterase inhibitor CBDP. Neurotoxicology 31(5):502-508
42. Ellman GL et al (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88-95
43. Schmued LC et al (2005) Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons. Brain Res 1035(1):24-31
44. Schmued LC, Albertson C, Slikker W (1997) Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res 751(1):37-46
45. Keith BJ, Franklin GP (2008) The mouse brain in stereotaxic coordinates, 3rd edn. Academic Press, New York
46. Harvey AT et al (1994) Monoamine activity in anterior hypothalamus of guinea pig pups separated from their mothers. Behav Neurosci 108(1):171-176
47. Lucot JB et al (2005) Measurement of plasma catecholamines in small samples from mice. J Pharmacol Toxicol Methods 52(2):274-277
48. Bloch-Shilderman E et al (2008) Subchronic exposure to low-doses of the nerve agent VX: physiological, behavioral, histopathological and neurochemical studies. Toxicol Appl Pharmacol 231(1):17-23
49. Choudhary S et al (2002) Possible involvement of dopaminergic neurotransmitter system in dichlorvos induced delayed neurotoxicity. J Biochem Mol Biol Biophys 6(1):29-36
50. Fuxe K et al (1974) Origin of dopamine nerve-terminals in limbic and frontal cortex - evidence for meso-cortico dopamine neurons. Brain Res 82(2):349-355
51. Oades RD, Halliday GM (1987) Ventral tegmental (A10) system - neurobiology. 1. Anatomy and connectivity. Brain Res Rev 12(2):117-165
52. White FJ (1996) Synaptic regulation of mesocorticolimbic dopamine neurons. Annu Rev Neurosci 19:405-436
53. Fallon JH, Koziell DA, Moore RY (1978) Catecholamine innervation of basal forebrain II. Amygdala, suprarhinal cortex and entorhinal cortex. J Compar Neurol 180(3):509-531
54. Inglis FM, Moghaddam B (1999) Dopaminergic innervation of the amygdala is highly responsive to stress. J Neurochem 72(3):1088-1094
55. Hasue RH, Shammah-Lagnado SJ (2002) Origin of the dopaminergic innervation of the central extended amygdala and accumbens shell: a combined retrograde tracing and immunohistochemical study in the rat. J Compar Neurol 454(1):15-33
56. Padilla S et al (2005) Neurochemical effects of chronic dietary and repeated high-level acute exposure to chlorpyrifos in rats. Toxicol Sci 88(1):161-171
57. Pope CN et al (1992) Long-term neurochemical and behavioral effects induced by acute chlorpyrifos treatment. Pharmacol Biochem Behav 42(2):251-256
58. Rausch JL et al (1985) Physostigmine effects on serotonin uptake in human-blood platelets. Eur J Pharmacol 109(1):91-96
59. Oquendo MA, Mann JJ (2000) The biology of impulsivity and suicidality. Psychiatr Clin North Am 23(1):11-25
60. Roldan-Tapia L et al (2006) Neuropsychological sequelae from acute poisoning and long-term exposure to carbamate and organophosphate pesticides. Neurotoxicol Teratol 28(6):694-703
61. London L et al (2005) Suicide and exposure to organophosphate insecticides: cause or effect? Am J Ind Med 47(4):308-321
62. Slotkin TA, Seidler FJ (2007) Comparative developmental neurotoxicity of organophosphates in vivo: transcriptional responses of pathways for brain cell development, cell signaling, cytotoxicity and neurotransmitter systems. Brain Res Bull 72(4-6):232-274